胸腺基質(zhì)淋巴細胞生成素(TSLP)活性蛋白
Active Thymic Stromal Lymphopoietin (TSLP)
- 編號APB320Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 95%
- 等電點9.6
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1872 ¥ 4680 ¥ 9360 ¥ 28080 ¥ 70200
- 欲了解實際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
活性實驗
Thymic stromal lymphopoietin (TSLP) is a member of the IL-2 cytokine family and a distant paralog of IL-7. TSLP is a pleiotropic cytokine that acts on multiple cell lineages, including dendritic cells, T cells, B cells, neutrophils, mast cells, eosinophils and innate lymphoid cells, affecting their maturation, survival and recruitment. It is best known for its role in promoting type 2 immune responses such as in allergic diseases. Interleukin 13 (IL13) is a critical downstream element for TSLP-driven allergic inflammation. Thus a functional binding ELISA assay was conducted to detect the interaction of recombinant human TSLP and recombinant bovine IL13. Briefly, TSLP was diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100 μl were then transferred to IL13-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST and incubated for 1h with anti-TSLP pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody for 1h at 37℃, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 μL stop solution to the wells and read at 450/630 nm immediately. The binding activity of recombinant human TSLP and recombinant bovine IL13 was shown in Figure 1, the EC50?for this effect is 0.11 ug/mL.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPB320Hu02 | 胸腺基質(zhì)淋巴細胞生成素(TSLP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB320Hu03 | 胸腺基質(zhì)淋巴細胞生成素(TSLP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB320Hu01 | 胸腺基質(zhì)淋巴細胞生成素(TSLP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APB320Hu01 | 胸腺基質(zhì)淋巴細胞生成素(TSLP)活性蛋白 | Cell?culture;?Activity?Assays. |
PAB320Hu01 | 胸腺基質(zhì)淋巴細胞生成素(TSLP)多克隆抗體 | WB; IHC; ICC; IP. |
MAB320Hu22 | 胸腺基質(zhì)淋巴細胞生成素(TSLP)單克隆抗體 | WB; IHC; ICC; IP. |
MAB320Hu27 | 胸腺基質(zhì)淋巴細胞生成素(TSLP)單克隆抗體 | WB; IHC; ICC; IP. |
MAB320Hu29 | 胸腺基質(zhì)淋巴細胞生成素(TSLP)單克隆抗體 | WB; IHC; ICC; IP. |
MAB320Hu21 | 胸腺基質(zhì)淋巴細胞生成素(TSLP)單克隆抗體 | WB; IHC; ICC; IP. |
MAB320Hu23 | 胸腺基質(zhì)淋巴細胞生成素(TSLP)單克隆抗體 | WB; IHC; ICC; IP. |
MAB320Hu24 | 胸腺基質(zhì)淋巴細胞生成素(TSLP)單克隆抗體 | WB; IHC; ICC; IP. |
MAB320Hu25 | 胸腺基質(zhì)淋巴細胞生成素(TSLP)單克隆抗體 | WB; IHC; ICC; IP. |
HEB320Hu | 胸腺基質(zhì)淋巴細胞生成素(TSLP)檢測試劑盒(酶聯(lián)免疫吸附試驗法,高敏型) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SEB320Hu | 胸腺基質(zhì)淋巴細胞生成素(TSLP)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCB320Hu | 胸腺基質(zhì)淋巴細胞生成素(TSLP)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
LMB320Hu | 胸腺基質(zhì)淋巴細胞生成素(TSLP)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
Journal of Interferon & Cytokine Research | Epithelial Cell-Derived Cytokines Contribute to the Pathophysiology of Eosinophilic Chronic Rhinosinusitis [Pubmed:26540312] |
Allergology International | The effect of calprotectin on TSLP and IL-25 production from airway epithelial cells [pubmed:27475624] |
International Journal of Molecular?Sciences | Topical Application of JAK1/JAK2 Inhibitor Momelotinib Exhibits Significant Anti-Inflammatory Responses in DNCB-Induced Atopic Dermatitis Model Mice [Pubmed: 30544712] |
Dermatol Reports | Skin tissue expression and serum level of thymic stromal lymphopoietin in patients with psoriasis vulgaris [Pubmed: 31316739] |